Literature DB >> 6978799

Mitral regurgitation in coronary artery disease.

V Balu, S Hershowitz, A R Zaki Masud, J N Bhayana, D C Dean.   

Abstract

Over a period of 5.25 years, 1,530 patients with coronary artery disease (CAD) underwent catheterization; 104 had associated mitral regurgitation (MR), and 60 had no complications. Twelve patients underwent coronary artery bypass graft surgery (CABG), with both pre- and postoperative angiograms. Nine of the 12 patients (75 percent) were in functional class 3 or 4. Left ventricular ejection fraction ranged from 34 to 75. The MR was considered severe (3+) in three, moderate (2+) in six, and trivial (1+) in three patients. Following CABG, all except two patients were in class 1. Of the 43 patients medically treated, 31 patients (72 percent) were in functional class 3 or 4. Angiographic results showed that five patients had 3+ MR, 14 had 2+ MR, and 24 had 1+ MR. The EF was less than 30 in 23 patients and greater than or equal to 30 in 20 patients, and left ventricular filling pressure was elevated. Twenty patients died, with a mean follow-up period of 11 months. Our study demonstrates that the surgically treated patients showed angiographic improvement in MR, improved functional status, and relief of symptoms compared with medically treated patients. We believe that a subset of patients with MR and CAD would benefit with CABG.

Entities:  

Mesh:

Year:  1982        PMID: 6978799     DOI: 10.1378/chest.81.5.550

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Surgical options for the management of ischemic cardiomyopathy.

Authors:  Robert Michler
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 2.  Ischemic and functional mitral regurgitation in heart failure: natural history and treatment.

Authors:  Mina M Benjamin; Robert L Smith; Paul A Grayburn
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

3.  Mitral valve repair is not always needed in patients with functional mitral regurgitation undergoing coronary artery bypass grafting and/or aortic valve replacement.

Authors:  J E Lindeboom; W Jaarsma; J C Kelder; W J Morshuis; C A Visser
Journal:  Neth Heart J       Date:  2005-05       Impact factor: 2.380

4.  Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network.

Authors:  Peter K Smith; Robert E Michler; Y Joseph Woo; John H Alexander; John D Puskas; Michael K Parides; Rebecca T Hahn; Judson B Williams; John M Dent; T Bruce Ferguson; Ellen Moquete; Eric A Rose; Pierre Pagé; Neal O Jeffries; Patrick T O'Gara; Deborah D Ascheim
Journal:  J Thorac Cardiovasc Surg       Date:  2011-07-23       Impact factor: 5.209

5.  Risk of combined coronary artery bypass and mitral valve replacement.

Authors:  S S Kabbani; T T Bashour; E S Hanna; D Ellertson
Journal:  Tex Heart Inst J       Date:  1984-12

6.  Coronary artery bypass grafting alone for advanced ischemic left ventricular dysfunction with significant mitral regurgitation: early and midterm outcomes in a small series.

Authors:  Noyan Temucin Ogus; Melih Hulusi Us; Halide Ogus; Omer Isik
Journal:  Tex Heart Inst J       Date:  2004

7.  The outcome and criteria for mitral valve surgery in patients with ischemic mitral regurgitation.

Authors:  Atsushi Yamaguchi; Koji Kawahito; Hideo Adachi; Takashi Ino
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-09

Review 8.  Ischemic Mitral Regurgitation: A Multifaceted Syndrome with Evolving Therapies.

Authors:  Mattia Vinciguerra; Francesco Grigioni; Silvia Romiti; Giovanni Benfari; David Rose; Cristiano Spadaccio; Sara Cimino; Antonio De Bellis; Ernesto Greco
Journal:  Biomedicines       Date:  2021-04-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.